Marucci Anthony S has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 300000 shares of Celldex Therapeutics, Inc. ($CLDX) on June 05, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Celldex Therapeutics, Inc. | $CLDX | Marucci Anthony S | PRESIDENT & CEO | A | Incentive Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 66,383 | 9999.99% | 100.00% |
| Nov. 11, 2024 | Celldex Therapeutics, Inc. | $CLDX | Marucci Anthony S | PRESIDENT & CEO | P | Common Stock | 11500 | $26.82 | 40,284.0000 | 66,294 | 39.95% | 17.35% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | Marucci Anthony S | PRESIDENT & CEO | A | Incentive Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 58,871 | 9999.99% | 100.00% |
| June 15, 2023 | Celldex Therapeutics, Inc. | $CLDX | Marucci Anthony S | PRESIDENT & CEO | A | Incentive Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 47,214 | 9999.99% | 100.00% |